ATM and melanoma: Regarding melanoma, while risk estimates were not reliable for most genes due to a smaller melanoma cohort size, PVs in CDKN2A were expectedly associated with very high risks for melanoma (OR = 114.6); however, PVs in ATM and BRCA1 were also elevated (two- to threefold increased risks).